pH-Dependent Release Mechanisms for Environmental Remediation and Monitoring

Publication ID: 24-11857629_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “pH-Dependent Release Mechanisms for Environmental Remediation and Monitoring,” Published Technical Disclosure No. 24-11857629_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857629_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,629.

Summary of the Inventive Concept

A novel application of pH-dependent release mechanisms, originally developed for abuse-deterrent pharmaceutical compositions, to address pressing environmental challenges, including pollution, oil spills, wildfires, agricultural pests, and industrial wastewater treatment.

Background and Problem Solved

The original patent disclosed pH-dependent release mechanisms for abuse-deterrent pharmaceutical compositions. However, the limitations of this technology were confined to pharmaceutical applications. The new inventive concept addresses the pressing need for innovative solutions to environmental problems by adapting the core technology to novel use cases.

Detailed Description of the Inventive Concept

The new inventive concept leverages the pH-dependent release mechanism to encapsulate remediation agents, pesticides, fire-suppressing agents, or other environmentally beneficial substances. These agents are released in response to specific pH levels indicative of environmental pollution, oil spills, wildfires, pest presence, or wastewater contamination. The buffering ingredient retards the release of the acid soluble ingredient until the predetermined pH level is reached, ensuring targeted and controlled delivery of the remediation agents.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift by applying the pH-dependent release mechanism to entirely new industries and problems, demonstrating a non-obvious and innovative adaptation of the original technology.

Alternative Embodiments and Variations

Alternative embodiments may include using different types of buffering ingredients, acid soluble ingredients, or encapsulation materials. Variations could involve adapting the pH-dependent release mechanism for use in other environmental applications, such as monitoring and controlling air pollution or detecting and responding to natural disasters.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in various environmental industries, including pollution remediation, oil spill response, wildfire management, agricultural pest control, and industrial wastewater treatment. The market for these applications is substantial, with growing demand for innovative, targeted, and environmentally responsible solutions.

CPC Classifications

SectionClassGroup
A A61 A61K47/02
A A61 A61K9/2009
A A61 A61K9/2027
A A61 A61K9/2077
A A61 A61K31/5517
A A61 A61K47/32

Field of Art

Pharmaceutical formulation and controlled release technologies, with expertise in drug delivery mechanisms, pH-dependent release systems, and environmental remediation technologies

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences, chemical engineering, or materials science, possessing knowledge of controlled release mechanisms, buffering systems, and interdisciplinary applications of drug delivery technologies

Obviousness Rationale

A PHOSITA would recognize the fundamental similarity between the source patent's pH-dependent pharmaceutical release mechanism and the PTD's environmental application as a straightforward technological translation. The core principle of controlled release triggered by specific pH conditions remains consistent across both contexts, suggesting an obvious extension of the original pharmaceutical technology to environmental monitoring and remediation systems.

Obvious Combinations & Variations

Source Patent Element
pH-dependent buffering mechanism for controlling drug release
PTD Variation
Applying the same pH-triggered release mechanism to environmental remediation agents
Obviousness Reasoning
Known technique of adapting controlled release technologies across different domains, with predictable results in targeting specific environmental conditions
Source Patent Element
Abuse-deterrent composition with acid soluble and buffering ingredients
PTD Variation
Using similar compositional approach for encapsulating pesticides and fire-suppressing agents
Obviousness Reasoning
Finite set of known encapsulation strategies, with predictable performance when applied to different active ingredients
Source Patent Element
Controlling peak plasma concentration through pH modulation
PTD Variation
Controlling release of environmental agents based on pH indicators of specific conditions
Obviousness Reasoning
Established principle of using pH as a trigger for controlled release, extending to new application domains with expected consistent performance
Source Patent Element
Composition with pharmaceutically active ingredient and buffering system
PTD Variation
Composition with remediation agents and pH-responsive release mechanism
Obviousness Reasoning
Obvious design choice to translate pharmaceutical controlled release principles to environmental monitoring technologies
Source Patent Element
Targeted release of active ingredients based on specific conditions
PTD Variation
Targeted release of environmental agents based on pH indicators
Obviousness Reasoning
Predictable application of known controlled release strategies across different technical domains
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857629, a person having ordinary skill in the art would find the environmental remediation applications disclosed herein to be an obvious extension of known pH-dependent controlled release technologies. The fundamental principles of targeted, condition-specific release mechanisms remain consistent across pharmaceutical and environmental domains, rendering the claimed variations obvious to a skilled practitioner.

Original Patent Information

Patent NumberUS 11,857,629
TitleMethods and compositions for self-regulated release of active pharmaceutical ingredient
Assignee(s)Acurx Pharmaceuticals, Inc.